Abdominoplasty Clinical Trial
Official title:
Clinical Evaluation of the Cohera TissuGlu Device in the Management of Wound Drainage Following Abdominoplasty
A blinded, prospective, randomized trial in 40 abdominoplasty cases at three sites to study the safety and the preliminary efficacy of TissuGlu®, a novel surgical adhesive, in the management of wound drainage during abdominoplasty procedures.
Status | Completed |
Enrollment | 40 |
Est. completion date | May 2010 |
Est. primary completion date | May 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Be at least 20 years of age; - Be in good general health in the opinion of the Investigator with no conditions that would significantly impact wound healing as determined by medical history and review of recent concomitant medications; - Be scheduled for at least one full thickness surgical incision of at least 20cm in length as part of elective abdominoplasty requiring the placement of sutures in the superficial fascia and subcutaneous tissue to relieve skin tension prior to final skin closure, Surgeon must use electrocautery in the procedure; - Be willing to follow instructions for incision care, comply with schedule for wound drainage volume measurements, and follow guidelines related to resumption of daily activities; - Agree to return for all follow-up evaluations specified in this protocol; - Agree not to schedule any additional elective surgical procedures that involve an incision until their participation in this study is complete; and - Sign the informed consent. Exclusion Criteria: - Anesthesia Risk judged to be higher than ASA2 - Previous Abdominoplasty - Have severe co-morbid conditions that pose a high risk for surgery and adequate recovery (e.g., heart disease) - Any condition involving compromised vascular flow to the abdominal wall tissue. Prior abdominal scars, especially subcostal scars, will be a relative contraindication and judged on a case by case basis by the surgeon investigator. - Any condition known to effect wound healing, such as collagen vascular disease - Current active tobacco use, including smokeless (chewing) tobacco - Obesity, as defined by BMI >30 - Known blood clotting disorder - Current diagnosis of diabetes - Be receiving antibiotic therapy for pre-existing condition or infection - Have known personal or family history of keloid formation or hypertrophy - Undergoing concurrent adjacent or congruent Liposuction procedures - Concurrent use of fibrin sealants or other internal wound care devices - Be currently taking systemic steroids or immunosuppressive agents - Concurrent hernia repair greater than 6 cm and/or requiring the use of mesh - Mini abdominoplasty (Abdominoplasty without umbilical transposition) - Have known or suspected allergy or sensitivity to any test materials or reagents - Be participating in any current clinical trial or have participated in any clinical trial within 30 days of enrollment in this study - Pregnancy (30 days post-op) |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Germany | University of Bonn | Bonn | |
Germany | Rosenpark Klinik | Darmstadt | |
Germany | Erich-Lexer-Klinik | Freiburg |
Lead Sponsor | Collaborator |
---|---|
Cohera Medical, Inc. |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | • Safety data will be gathered with respect to the number, timing, severity, duration and resolution of device and non-device related adverse events occurring among study subjects. | Discharge, 14, 30, 60, 90 Day follow-up | Yes | |
Secondary | • Time to drain removal based upon a drain removal criteria of <30ml of fluid accumulation in a twenty four (24) hour period (Scevola et al, 2002; Momeni et al, 2008). | Assessed at time of drain removal- Average 2 to 5 days post surgery. | No | |
Secondary | • Number of wound complications, seroma formation, wound dehiscence, infection, skin necrosis, hematoma | Discharge, 14, 30, 60, 90 Day follow-up | No | |
Secondary | • Cumulative drainage volume for each patient | Assessed at time of drain removal- Average 2-5 days post surgery. | No | |
Secondary | • Number of additional physician or clinic visits | Discharge, 14, 30, 60, 90 Day follow-up | No | |
Secondary | • Number/type of additional procedures due to complications | Discharge, 14, 30, 60, 90 Day follow-up | No | |
Secondary | • Evaluation of the delivery method/delivery device (Surgeon questionnaire) | Questionnaire completed by the surgeon after the surgery rating ergonomics, visibility, ability to deliver the adhesive and overall satisfaction with the delivery method. | Assessed at time of surgery/use of the device (Day 0) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03143959 -
Functional Improvement With Abdominoplasty
|
N/A | |
Active, not recruiting |
NCT04207047 -
Histologic Evaluation of Tissue Following Lutronic System Exposure
|
N/A | |
Active, not recruiting |
NCT04712331 -
Effect of Abdominal Exercises and Russian Stimulation on The Abdominal Muscles Strength After Abdominoplasty
|
N/A | |
Completed |
NCT02949778 -
Quadratus Lumborum Block for Abdominoplasty
|
Phase 4 | |
Active, not recruiting |
NCT01026662 -
In-vivo Analysis of a Fractional CO2 Laser System (eMatrixCO2) Intended for Treatment of Soft Tissue
|
Phase 2/Phase 3 | |
Withdrawn |
NCT03770195 -
Registry Study for the Use of HEMOBLAST™ Bellows in Abdominoplasty
|
||
Terminated |
NCT03429556 -
Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty
|
Phase 2 | |
Terminated |
NCT02302222 -
The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing
|
N/A | |
Recruiting |
NCT05939518 -
Fluid Therapy and Glycocalyx Shedding During Moderate Surgery
|
N/A | |
Active, not recruiting |
NCT05490602 -
Comparison Study in Different Sutures Techniques in Reduction of Known Abdominoplasty Complications and Improving Patients' Post-operative Outcomes
|
||
Completed |
NCT01389635 -
Abdominoplasty Under Epidural Anesthesia
|
N/A | |
Recruiting |
NCT04670224 -
Efficiency of the Quadratus Lumborum Block for Post-operative Analgesia in Abdominoplasty Surgery
|
N/A | |
Recruiting |
NCT03190876 -
Seroma Prevention After Body Contouring Procedures
|
N/A | |
Recruiting |
NCT04787874 -
Effect of Prehabilitation on Surgical Outcomes of Abdominally-based Plastic Surgery Procedures
|
N/A | |
Completed |
NCT01604694 -
Ultrasound-guided Transversus Abdominis Plane Block for Analgesia After Abdominoplasty
|
Phase 4 | |
Withdrawn |
NCT02140385 -
Role of Preservation of Scarpa's Fascia in Abdominoplasty
|
N/A | |
Completed |
NCT04182880 -
Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain
|
Phase 2 | |
Completed |
NCT03467724 -
Treatment of Surgical Scars Following Breast Augmentation, Abdominoplasty or Face Lift
|
N/A | |
Not yet recruiting |
NCT02930447 -
Evaluation of the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty
|
N/A | |
Enrolling by invitation |
NCT06043557 -
Patient Satisfaction and Reflection on Drain Placement
|
N/A |